Sex-Specific Association between Underlying Diseases and the Severity and Mortality Due to COVID-19 Infection: A Retrospective Observational Cohort Analysis of Clinical Epidemiological Information Collected by the Korea Disease Control and Prevention Agency

Author:

Oh Hwayeong,Kim RoeulORCID,Chung WoojinORCID

Abstract

This study is a retrospective observational cohort analysis aiming to explore the relationship between underlying disease and the severity and mortality rate of coronavirus disease (COVID-19) by sex. As sample subjects, 5077 confirmed COVID-19 patients were selected. The dependent variable was each patient’s clinical severity, dichotomized into two groups: clinical non-severity group and clinical severity group (including death group). Eleven underlying diseases were considered variables of interest, and each was dichotomized. Binary multivariate logistic regression model analyses were performed. Our results showed that the proportion of male patients (7.1%) in the clinical severity group was significantly higher than that of female patients (4.5%) and that the risk of being in the clinical severity group was higher in patients with specific underlying diseases. The underlying diseases varied: in males, rheumatism and autoimmune (adjusted odds ratio (aOR) = 6.69, 95% confidence interval (CI) = 1.60–27.98), dementia (aOR = 4.09, 95% CI = 2.14–7.82), cancer (aOR = 2.69, 95% CI = 1.27–5.69), and diabetes mellitus (aOR = 1.81, 95% CI = 1.18–2.77); in females, chronic kidney disease (aOR = 5.09, 95% CI = 1.87–13.86), dementia (aOR = 3.08, 95% CI = 1.18–5.23), diabetes mellitus (aOR = 1.87, 95% CI = 1.15–3.02), and hypertension (aOR = 1.73, 95% CI = 1.08–2.78). This study identified certain underlying diseases related to the high risk of being in clinically severe conditions and found that they differ between sexes. Prevention and treatment measure should be developed to reduce severity or mortality in confirmed COVID-19, based on underlying diseases and sex. However, further in-depth research is required to explore whether the findings and suggestions of this study can be generalized to other countries.

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference38 articles.

1. Coronavirus Disease (COVID-19);World Health Organization (WHO)

2. What is COVID-19?;Ministry of Health and Welfare (MOHW)

3. WHO Director-General’s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020;World Health Organization (WHO)

4. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—30 March 2020;World Health Organization (WHO)

5. Domestic Occurrences;Ministry of Health and Welfare (MOHW)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3